Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Statistics

Total Valuation

BME:PANG has a market cap or net worth of EUR 55.31 million. The enterprise value is 57.75 million.

Market Cap	55.31M
Enterprise Value	57.75M

Important Dates

The last earnings date was Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BME:PANG has 35.91 million shares outstanding. The number of shares has increased by 19.14% in one year.

Current Share Class	35.91M
Shares Outstanding	35.91M
Shares Change (YoY)	+19.14%
Shares Change (QoQ)	-1.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.18%
Float	10.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.31
PB Ratio	2.51
P/TBV Ratio	3.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.06
EV / Sales	3.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.46

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.22.

Current Ratio	1.78
Quick Ratio	1.47
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-1.60
Interest Coverage	-13.05

Financial Efficiency

Return on equity (ROE) is -15.89% and return on invested capital (ROIC) is -16.69%.

Return on Equity (ROE)	-15.89%
Return on Assets (ROA)	-7.54%
Return on Invested Capital (ROIC)	-16.69%
Return on Capital Employed (ROCE)	-15.65%
Weighted Average Cost of Capital (WACC)	4.19%
Revenue Per Employee	101,417
Profits Per Employee	-21,795
Employee Count	159
Asset Turnover	0.52
Inventory Turnover	3.64

Taxes

Income Tax	-456,313
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.98% in the last 52 weeks. The beta is -0.02, so BME:PANG's price volatility has been lower than the market average.

Beta (5Y)	-0.02
52-Week Price Change	-10.98%
50-Day Moving Average	1.66
200-Day Moving Average	1.69
Relative Strength Index (RSI)	21.07
Average Volume (20 Days)	6,716

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:PANG had revenue of EUR 16.73 million and -3.60 million in losses. Loss per share was -0.10.

Revenue	16.73M
Gross Profit	14.15M
Operating Income	-3.89M
Pretax Income	-4.02M
Net Income	-3.60M
EBITDA	-2.60M
EBIT	-3.89M
Loss Per Share	-0.10

Balance Sheet

The company has 3.07 million in cash and 4.76 million in debt, with a net cash position of -1.68 million or -0.05 per share.

Cash & Cash Equivalents	3.07M
Total Debt	4.76M
Net Cash	-1.68M
Net Cash Per Share	-0.05
Equity (Book Value)	22.06M
Book Value Per Share	0.59
Working Capital	5.62M

Cash Flow

In the last 12 months, operating cash flow was -2.52 million and capital expenditures -448,471, giving a free cash flow of -2.97 million.

Operating Cash Flow	-2.52M
Capital Expenditures	-448,471
Depreciation & Amortization	1.29M
Net Borrowing	213,916
Free Cash Flow	-2.97M
FCF Per Share	-0.08

Margins

Gross margin is 84.56%, with operating and profit margins of -23.25% and -21.49%.

Gross Margin	84.56%
Operating Margin	-23.25%
Pretax Margin	-24.05%
Profit Margin	-21.49%
EBITDA Margin	-15.55%
EBIT Margin	-23.25%
FCF Margin	n/a

Dividends & Yields

BME:PANG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.14%
Shareholder Yield	-19.14%
Earnings Yield	-6.50%
FCF Yield	-5.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:PANG has an Altman Z-Score of 3.07 and a Piotroski F-Score of 3.

Altman Z-Score	3.07
Piotroski F-Score	3